CIENCIA INC
East Hartford, CT · Medtech · Private
Grating-coupled fluorescent plasmonics (GC-FP) assay platform for multi-antigen serologic testing of Lyme disease and tick-borne diseases
ciencia.com →- Grants
- $1.8M
- 6 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $1.5M
- 2 awards · Health and Human S, Defense
- #261 of 4531 in medtech
- Patents
- 6
- 4 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20022004200620082010201220142016201820202022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services | $749,540 | |
| Federal contract | Department of Defense · 200512!502165!9700!HDTRA1!DEFENSE Threat Reduction Agency !HDTRA105C0031 !a!n! !n! ! !20050715!20070614!616818738!616818738!616818738!N!CIENCIA Inc !111 Roberts St Ste K !east Hartford !CT!06108!22700!003!09!EAST Hartford !hartford !conn !+000000750000!N!N!000000750000!AD91!RDTE/OTHER Defense-basic Research !S1 !services !000 !* !541710!E! !3! ! ! ! ! !202 | $750,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Measuring toxicant effects on cellular function in a microarray format | $224,997 | |
| Federal grant | Department of Health and Human Services · Phase I · Simultaneous kinetic analyses of neuronal connectivities | $150,253 | |
| Federal grant | Department of Health and Human Services · Phase II · Measuring toxicant effects on cellular function in a microarray format | $500,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Measuring toxicant effects on cellular function in a microarray format | $438,132 | |
| Federal grant | Department of Health and Human Services · Phase I · Highly-sensitive, rapid and low cost plasmonic assay platform for Lyme disease diagnosis | $259,613 | |
| Federal grant | Department of Health and Human Services · Phase I · Highly-sensitive, rapid and low cost plasmonic assay platform for Lyme disease diagnosis | $259,613 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 258 | Micro-Leads,Inc. | $1.5M | — |
| 259 | OPSENS INC | $1.5M | $99K |
| 260 | HEARING COMPONENTS, INC. | $1.5M | — |
| 261 | CIENCIA INC | $1.5M | — |
| 262 | FOOTHOLD LABS INC | $1.5M | $4K |
| 263 | YOUV LABS | $1.5M | — |
| 264 | PAPGENE, INC. | $1.5M | $3.0M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Surface Plasmon Enhanced Photocatalysisgranted
- Electro-Optic Grating-Coupled Surface Plasmon Resonance (EOSPR)granted
- Electro-Optic Grating-Coupled Surface Plasmon Resonance (EOSPR)granted
- Versatile Surface Plasmon Resonance Analyzer With An Integral Surface Plasmon Resonance Enhanced Fluorescence Modegranted
- Surface Plasmon Enhanced Photocatalysisapplication
- Electro-Optic Grating-Coupled Surface Plasmon Resonance (EOSPR)application
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.